Analysts: Glenmark Pharmaceuticals Ltd (GLEN.NS)

GLEN.NS on National Stock Exchange of India

719.15INR
30 Jan 2015
Change (% chg)

Rs0.10 (+0.01%)
Prev Close
Rs719.05
Open
Rs724.90
Day's High
Rs731.85
Day's Low
Rs715.80
Volume
614,306
Avg. Vol
680,419
52-wk High
Rs841.00
52-wk Low
Rs507.10

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -- March 31 Jan 2015

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 12 11 11 10
(2) OUTPERFORM 15 15 15 14
(3) HOLD 5 7 7 8
(4) UNDERPERFORM 2 2 2 2
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.91 2.00 2.00 2.06

Consensus Estimates Analysis

Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-15 2 19,052.10 19,619.00 18,485.30 --
Year Ending Mar-15 29 69,244.70 71,452.00 66,466.20 69,670.80
Year Ending Mar-16 29 81,244.80 85,579.00 75,345.00 80,854.30
Earnings (per share)
Year Ending Mar-15 30 29.86 33.20 25.45 32.34
Year Ending Mar-16 30 38.51 50.80 31.15 38.82
LT Growth Rate (%) 3 24.40 38.00 14.50 23.90

Historical Surprises

Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-14 16,239.90 16,715.30 475.41 2.93
Quarter Ending Jun-14 14,922.80 14,778.20 144.63 0.97
Quarter Ending Mar-14 16,053.10 16,817.40 764.28 4.76
Quarter Ending Dec-13 15,616.80 16,012.20 395.42 2.53
Quarter Ending Sep-13 14,695.20 14,630.10 65.10 0.44
Earnings (per share)
Quarter Ending Sep-14 7.63 6.08 1.55 20.31
Quarter Ending Jun-14 6.20 6.81 0.61 9.75
Quarter Ending Mar-14 7.15 9.62 2.47 34.54
Quarter Ending Dec-13 6.90 7.97 1.07 15.46
Quarter Ending Sep-13 6.38 5.69 0.69 10.87

Consensus Estimates Trend

Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-15 19,052.10 19,952.00 19,952.00 19,952.00 --
Year Ending Mar-15 69,244.70 69,395.10 69,557.30 69,620.00 69,670.80
Year Ending Mar-16 81,244.80 81,414.50 81,644.30 81,664.00 80,854.30
Earnings (per share)
Year Ending Mar-15 29.86 30.25 30.56 30.73 32.34
Year Ending Mar-16 38.51 38.94 38.98 39.05 38.82

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-15 0 1 0 1
Year Ending Mar-15 0 2 2 4
Year Ending Mar-16 0 2 2 4
Earnings
Year Ending Mar-15 0 3 0 8
Year Ending Mar-16 0 3 2 5

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00
Provider: Reuters Investment Profile
$20.00
Provider: Sadif Analytics Prime
$25.00
Provider: Motilal Oswal Securities Ltd.
$81.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks